Average Co-Inventor Count = 4.02
ph-index = 18
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (21 from 3,223 patents)
2. Graybug Vision, Inc. (11 from 12 patents)
3. Amunix Operating Inc. (10 from 24 patents)
4. Amunix Pharmaceuticals, Inc (2 from 9 patents)
5. Genetech, Inc. (1 from 98 patents)
6. Nuron Biotech, Inc. (1 from 1 patent)
7. Graybug Visioon, Inc. (1 from 1 patent)
8. Johns Hopkins University (3,688 patents)
47 patents:
1. 12071456 - Extended recombinant polypeptides and compositions comprising same
2. 11564890 - Aggregating microparticles for medical therapy
3. 11548861 - Drugs and compositions for the treatment of ocular disorders
4. 11331276 - Aggregating microparticles for medical therapy
5. 11160870 - Extended release microparticles and suspensions thereof for medical therapy
6. 10961287 - Extended recombinant polypeptides and compositions comprising same
7. 10485876 - Compounds and compositions for the treatment of ocular disorders
8. 10441548 - Aggregating microparticles for medical therapy
9. 10159747 - Compounds and compositions for the treatment of ocular disorders
10. 10117950 - Compounds and compositions for the treatment of ocular disorders
11. 10111964 - Compounds and compositions for the treatment of ocular disorders
12. 10098965 - Compounds and compositions for the treatment of ocular disorders
13. 10000543 - Glucose-regulating polypeptides and methods of making and using same
14. 9956302 - Compounds and compositions for the treatment of ocular disorders
15. 9926351 - Extended recombinant polypeptides and compositions comprising same